Publications

Publications published since 2000 or in press from OUS - Department of Immunology Inst Cancer Res

360 publications found

Publications in press

1. Mobergslien A, Sioud M
   Exosome-Derived miRNAs and Cellular miRNAs Activate Innate Immunity
   J Innate Immun (in press)
   PubMed 23774807
2. Sioud M, Skorstad G, Mobergslien A, Sæbøe-Larssen S
   A novel peptide carrier for efficient targeting of antigens and nucleic acids to dendritic cells
   FASEB J (in press)
   PubMed 23671272
3. Wahlin BE, Sundström C, Sander B, Christensson B, Jeppsson-Ahlberg A, Hjalmarsson E, Holte H, Ostenstad B, Brown PD, Smeland EB, Kimby E
   Higher World Health Organization grades of follicular lymphoma correlate with better outcome in two Nordic Lymphoma Group trials of rituximab without chemotherapy
   Leuk Lymphoma (in press)
   PubMed 23662992
4. Wang P, Suo Z, Wang M, Høifødt HK, Fodstad O, Gaudernack G, Kvalheim G
   In vitro and in vivo properties of CD133 expressing cells from human lung cancer cell lines
   Exp Hematol Oncol, 2 (1), 16 (in press)
   PubMed 23738757
5. Yri OE, Ekstrøm PO, Hilden V, Gaudernack G, Liestøl K, Smeland EB, Holte H
   Influence of polymorphisms in genes encoding immunoregulatory proteins and metabolizing enzymes on susceptibility and outcome in patients with diffuse large B-cell lymphoma treated with rituximab
   Leuk Lymphoma (in press)
   PubMed 23391141

Publications 2013

1. Béziat V, Liu LL, Malmberg JA, Ivarsson MA, Sohlberg E, Björklund AT, Retière C, Sverremark-Ekström E, Traherne J, Ljungman P, Schaffer M, Price DA, Trowsdale J, Michaëlsson J, Ljunggren HG, Malmberg KJ (2013)
   NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs
   Blood, 121 (14), 2678-88
   PubMed 23325834
2. Béziat V, Traherne JA, Liu LL, Jayaraman J, Enqvist M, Larsson S, Trowsdale J, Malmberg KJ (2013)
   Influence of KIR gene copy number on natural killer cell education
   Blood, 121 (23), 4703-7
   PubMed 23637128
3. Bøe SL, Jørgensen JA, Longva AS, Lavelle T, Sæbøe-Larssen S, Hovig E (2013)
   Light-controlled modulation of gene expression using polyamidoamine formulations
   Nucleic Acid Ther, 23 (2), 160-5
   PubMed 23530684
4. Dollner R, Taraldsrud E, Iversen K, Osnes T, Kristensen B, Kramer MF (2013)
   Non-allergic, mastocytosis-associated rhinitis
   Clin Exp Allergy, 43 (4), 406-12
   PubMed 23517036
5. Green MR, Gentles AJ, Nair RV, Irish JM, Kihira S, Liu CL, Kela I, Hopmans ES, Myklebust JH, Ji H, Plevritis SK, Levy R, Alizadeh AA (2013)
   Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma
   Blood, 121 (9), 1604-11
   PubMed 23297126
6. Hasvold G, Nähse-Kumpf V, Tkacz-Stachowska K, Rofstad EK, Syljuåsen RG (2013)
   The Efficacy of CHK1 Inhibitors Is Not Altered by Hypoxia, but Is Enhanced after Reoxygenation
   Mol Cancer Ther, 12 (5), 705-16
   PubMed 23635654
7. Roed L, Grave G, Lindahl T, Rian E, Horndalsveen PO, Lannfelt L, Nilsson C, Swenson F, Lönneborg A, Sharma P, Sjögren M (2013)
   Prediction of Mild Cognitive Impairment that Evolves into Alzheimer's Disease Dementia within Two Years using a Gene Expression Signature in Blood: A Pilot Study
   J Alzheimers Dis, 35 (3), 611-21
   PubMed 23478308
8. Sioud M, Sæbøe-Larssen S, Hetland TE, Kærn J, Mobergslien A, Kvalheim G (2013)
   Silencing of indoleamine 2,3-dioxygenase enhances dendritic cell immunogenicity and antitumour immunity in cancer patients
   Int J Oncol, 43 (1), 280-8
   PubMed 23620105
9. Sternberg-Simon M, Brodin P, Pickman Y, Onfelt B, Kärre K, Malmberg KJ, Höglund P, Mehr R (2013)
   Natural killer cell inhibitory receptor expression in humans and mice: a closer look
   Front Immunol, 4, 65
   PubMed 23532016
10. Vanherberghen B, Olofsson PE, Forslund E, Sternberg-Simon M, Khorshidi MA, Pacouret S, Guldevall K, Enqvist M, Malmberg KJ, Mehr R, Önfelt B (2013)
    Classification of human natural killer cells based on migration behavior and cytotoxic response
    Blood, 121 (8), 1326-34
    PubMed 23287857
11. Wang P, Gao Q, Suo Z, Munthe E, Solberg S, Ma L, Wang M, Westerdaal NA, Kvalheim G, Gaudernack G (2013)
    Identification and characterization of cells with cancer stem cell properties in human primary lung cancer cell lines
    PLoS One, 8 (3), e57020
    PubMed 23469181

Publications 2012

1. Abrahamsen IW, Kjellevoll S, Greve-Isdahl M, Mensali N, Wälchli S, Kumari S, Loland BF, Egeland T, Kolstad A, Olweus J (2012)
   T cells raised against allogeneic HLA-A2/CD20 kill primary follicular lymphoma and acute lymphoblastic leukemia cells
   Int J Cancer, 130 (8), 1821-32
   PubMed 21630262
2. Adamczak M, Hoel HJ, Gaudernack G, Barbasz J, Szczepanowicz K, Warszy?ski P (2012)
   Polyelectrolyte multilayer capsules with quantum dots for biomedical applications
   Colloids Surf B Biointerfaces, 90, 211-6
   PubMed 22078925
3. Bakkebø M, Huse K, Hilden VI, Forfang L, Myklebust JH, Smeland EB, Oksvold MP (2012)
   SARA is dispensable for functional TGF-? signaling
   FEBS Lett, 586 (19), 3367-72
   PubMed 22819827
4. Banik D, Khan AN, Walseng E, Segal BH, Abrams SI (2012)
   Interferon regulatory factor-8 is important for histone deacetylase inhibitor-mediated antitumor activity
   PLoS One, 7 (9), e45422
   PubMed 23028998
5. Beck H, Nähse-Kumpf V, Larsen MS, O'Hanlon KA, Patzke S, Holmberg C, Mejlvang J, Groth A, Nielsen O, Syljuåsen RG, Sørensen CS (2012)
   Cyclin-dependent kinase suppression by WEE1 kinase protects the genome through control of replication initiation and nucleotide consumption
   Mol Cell Biol, 32 (20), 4226-36
   PubMed 22907750
6. Béziat V, Dalgard O, Asselah T, Halfon P, Bedossa P, Boudifa A, Hervier B, Theodorou I, Martinot M, Debré P, Björkström NK, Malmberg KJ, Marcellin P, Vieillard V (2012)
   CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients
   Eur J Immunol, 42 (2), 447-57
   PubMed 22105371
7. Björkström NK, Béziat V, Cichocki F, Liu LL, Levine J, Larsson S, Koup RA, Anderson SK, Ljunggren HG, Malmberg KJ (2012)
   CD8 T cells express randomly selected KIRs with distinct specificities compared with NK cells
   Blood, 120 (17), 3455-65
   PubMed 22968455
8. Blix ES, Irish JM, Husebekk A, Delabie J, Forfang L, Tierens AM, Myklebust JH, Kolstad A (2012)
   Phospho-specific flow cytometry identifies aberrant signaling in indolent B-cell lymphoma
   BMC Cancer, 12, 478
   PubMed 23072591
9. Blix ES, Irish JM, Husebekk A, Delabie J, Tierens AM, Myklebust JH, Kolstad A (2012)
   Altered BCR and CD40 signalling are associated with clinical outcome in small lymphocytic lymphoma/chronic lymphocytic leukaemia and marginal zone lymphoma patients
   Br J Haematol, 159 (5), 604-8
   PubMed 23043253
10. Huse K, Bakkebø M, Wälchli S, Oksvold MP, Hilden VI, Forfang L, Bredahl ML, Liestøl K, Alizadeh AA, Smeland EB, Myklebust JH (2012)
    Role of Smad proteins in resistance to BMP-induced growth inhibition in B-cell lymphoma
    PLoS One, 7 (10), e46117
    PubMed 23049692
11. Inderberg-Suso EM, Trachsel S, Lislerud K, Rasmussen AM, Gaudernack G (2012)
    Widespread CD4+ T-cell reactivity to novel hTERT epitopes following vaccination of cancer patients with a single hTERT peptide GV1001
    Oncoimmunology, 1 (5), 670-686
    PubMed 22934259
12. Knappskog S, Chrisanthar R, Løkkevik E, Anker G, Østenstad B, Lundgren S, Risberg T, Mjaaland I, Leirvaag B, Miletic H, Lønning PE (2012)
    Low expression levels of ATM may substitute for CHEK2 /TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer
    Breast Cancer Res, 14 (2), R47
    PubMed 22420423
13. Kumari S, Misra P, Tandon R, Samant M, Sundar S, Dube A (2012)
    Leishmania donovani: immunostimulatory cellular responses of membrane and soluble protein fractions of splenic amastigotes in cured patient and hamsters
    PLoS One, 7 (1), e30746
    PubMed 22292030
14. Malmberg KJ (2012)
    Toward a prime-boost regime for NK cells?
    Blood, 120 (24), 4663-4
    PubMed 23223209
15. Malmberg KJ, Beziat V, Ljunggren HG (2012)
    Spotlight on NKG2C and the human NK-cell response to CMV infection
    Eur J Immunol, 42 (12), 3141-5
    PubMed 23255011
16. Mobergslien A, Sioud M (2012)
    Galectin-1 and -3 gene silencing in immature and mature dendritic cells enhances T cell activation and interferon-? production
    J Leukoc Biol, 91 (3), 461-7
    PubMed 22167721
17. Nilsen G, Liestøl K, Van Loo P, Moen Vollan HK, Eide MB, Rueda OM, Chin SF, Russell R, Baumbusch LO, Caldas C, Børresen-Dale AL, Lingjaerde OC (2012)
    Copynumber: Efficient algorithms for single- and multi-track copy number segmentation
    BMC Genomics, 13, 591
    PubMed 23442169
18. Oksvold MP, Pedersen NM, Forfang L, Smeland EB (2012)
    Effect of cycloheximide on epidermal growth factor receptor trafficking and signaling
    FEBS Lett, 586 (20), 3575-81
    PubMed 22971756
19. Olweus J, Kolstad A (2012)
    [Can the immune system target cancer?]
    Tidsskr Nor Laegeforen, 132 (7), 784-5
    PubMed 22511078
20. Schmitz R, Young RM, Ceribelli M, Jhavar S, Xiao W, Zhang M, Wright G, Shaffer AL, Hodson DJ, Buras E, Liu X, Powell J, Yang Y, Xu W, Zhao H, Kohlhammer H, Rosenwald A, Kluin P, Müller-Hermelink HK, Ott G, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES et al. (2012)
    Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics
    Nature, 490 (7418), 116-20
    PubMed 22885699
21. Sioud M, Mobergslien A (2012)
    Selective killing of cancer cells by peptide-targeted delivery of an anti-microbial peptide
    Biochem Pharmacol, 84 (9), 1123-32
    PubMed 22922046
22. Sioud M, Mobergslien A (2012)
    Efficient siRNA Targeted Delivery into Cancer Cells by Gastrin-Releasing Peptides
    Bioconjug Chem, 23 (5), 1040-1049
    PubMed 22443209
23. Skjeldal FM, Strunze S, Bergeland T, Walseng E, Gregers TF, Bakke O (2012)
    The fusion of early endosomes induces molecular-motor-driven tubule formation and fission
    J Cell Sci, 125 (Pt 8), 1910-9
    PubMed 22357949
24. Taraldsrud E, Kjollesdal KS, Pripp AH, Solheim BG (2012)
    ABO identical versus ABO compatible plasma transfusions
    Vox Sang, 103 (2), 177-8
    PubMed 22348252
25. Tekle C, Nygren MK, Chen YW, Dybsjord I, Nesland JM, Maelandsmo GM, Fodstad O (2012)
    B7-H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis-associated genes
    Int J Cancer, 130 (10), 2282-90
    PubMed 21671471
26. Wahlin BE, Yri OE, Kimby E, Holte H, Delabie J, Smeland EB, Sundström C, Christensson B, Sander B (2012)
    Clinical significance of the WHO grades of follicular lymphoma in a population-based cohort of 505 patients with long follow-up times
    Br J Haematol, 156 (2), 225-33
    PubMed 22126847
27. Yri OE, Ekstrøm PO, Hilden V, Gaudernack G, Liestøl K, Smeland EB, Holte H (2012)
    Polymorphisms in genes encoding interleukin-10 and drug metabolizing enzymes GSTP1, GSTT1, GSTA1 and UGT1A1 influence risk and outcome in Hodgkin lymphoma
    Leuk Lymphoma, 53 (10), 1934-44
    PubMed 22475179
28. Zhen Y, Sørensen V, Skjerpen CS, Haugsten EM, Jin Y, Wälchli S, Olsnes S, Wiedlocha A (2012)
    Nuclear import of exogenous FGF1 requires the ER-protein LRRC59 and the importins Kpn?1 and Kpn?1
    Traffic, 13 (5), 650-64
    PubMed 22321063

Publications 2011

1. Alizadeh AA, Gentles AJ, Alencar AJ, Liu CL, Kohrt HE, Houot R, Goldstein MJ, Zhao S, Natkunam Y, Advani RH, Gascoyne RD, Briones J, Tibshirani RJ, Myklebust JH, Plevritis SK, Lossos IS, Levy R (2011)
   Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment
   Blood, 118 (5), 1350-8
   PubMed 21670469
2. Almåsbak H, Rian E, Hoel HJ, Pulè M, Wälchli S, Kvalheim G, Gaudernack G, Rasmussen AM (2011)
   Transiently redirected T cells for adoptive transfer
   Cytotherapy, 13 (5), 629-40
   PubMed 21174490
3. Brottveit M, Ráki M, Bergseng E, Fallang LE, Simonsen B, Løvik A, Larsen S, Løberg EM, Jahnsen FL, Sollid LM, Lundin KE (2011)
   Assessing possible celiac disease by an HLA-DQ2-gliadin Tetramer Test
   Am J Gastroenterol, 106 (7), 1318-24
   PubMed 21364548
4. Brunsvig PF, Kyte JA, Kersten C, Sundstrøm S, Møller M, Nyakas M, Hansen GL, Gaudernack G, Aamdal S (2011)
   Telomerase peptide vaccination in NSCLC: a phase II trial in stage III patients vaccinated after chemoradiotherapy and an 8-year update on a phase I/II trial
   Clin Cancer Res, 17 (21), 6847-57
   PubMed 21918169
5. Cameron MG, Kersten C, van Helvoirt R, Rohde G, Fosså SD, Vistad I (2011)
   Patient reported outcomes of symptoms and quality of life among cancer patients treated with palliative pelvic radiation: a pilot study
   BMC Res Notes, 4, 252
   PubMed 21777440
6. Eide MB, Lauritzsen GF, Kvalheim G, Kolstad A, Fagerli UM, Maisenhölder M, Østenstad B, Fluge Ø, Delabie J, Aarset H, Liestøl K, Holte H (2011)
   High dose chemotherapy with autologous stem cell support for patients with histologically transformed B-cell non-Hodgkin lymphomas. A Norwegian multi centre phase II study
   Br J Haematol, 152 (5), 600-10
   PubMed 21241276
7. Hunger RE, Kernland Lang K, Markowski CJ, Trachsel S, Møller M, Eriksen JA, Rasmussen AM, Braathen LR, Gaudernack G (2011)
   Vaccination of patients with cutaneous melanoma with telomerase-specific peptides
   Cancer Immunol Immunother, 60 (11), 1553-64
   PubMed 21681371
8. Huse K, Bakkebø M, Oksvold MP, Forfang L, Hilden VI, Stokke T, Smeland EB, Myklebust JH (2011)
   Bone morphogenetic proteins inhibit CD40L/IL-21-induced Ig production in human B cells: differential effects of BMP-6 and BMP-7
   Eur J Immunol, 41 (11), 3135-45
   PubMed 21898381
9. Josefsen D, Forfang L, Dyrhaug M, Blystad AK, Stokke T, Smeland EB, Kvalheim G (2011)
   Side population cells in highly enriched CD34-positive cells from peripheral blood progenitor cells identify an immature subtype of hematopoietic progenitor cells but do not predict time to engraftment in patients treated with high-dose therapy
   Eur J Haematol, 87 (6), 494-502
   PubMed 21752097
10. Kleist B, Xu L, Li G, Kersten C (2011)
    Expression of the adult intestinal stem cell marker Lgr5 in the metastatic cascade of colorectal cancer
    Int J Clin Exp Pathol, 4 (4), 327-35
    PubMed 21577318
11. Kyte JA, Gaudernack G, Dueland S, Trachsel S, Julsrud L, Aamdal S (2011)
    Telomerase peptide vaccination combined with temozolomide: a clinical trial in stage IV melanoma patients
    Clin Cancer Res, 17 (13), 4568-80
    PubMed 21586625
12. Landsverk KS, Patzke S, Rein ID, Stokke C, Lyng H, De Angelis PM, Stokke T (2011)
    Three independent mechanisms for arrest in G2 after ionizing radiation
    Cell Cycle, 10 (5), 819-29
    PubMed 21325885
13. Malumbres R, Fresquet V, Roman-Gomez J, Bobadilla M, Robles EF, Altobelli GG, Calasanz MJ, Smeland EB, Aznar MA, Agirre X, Martin-Palanco V, Prosper F, Lossos IS, Martinez-Climent JA (2011)
    LMO2 expression reflects the different stages of blast maturation and genetic features in B-cell acute lymphoblastic leukemia and predicts clinical outcome
    Haematologica, 96 (7), 980-6
    PubMed 21459790
14. Ngo VN, Young RM, Schmitz R, Jhavar S, Xiao W, Lim KH, Kohlhammer H, Xu W, Yang Y, Zhao H, Shaffer AL, Romesser P, Wright G, Powell J, Rosenwald A, Muller-Hermelink HK, Ott G, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Fisher RI et al. (2011)
    Oncogenically active MYD88 mutations in human lymphoma
    Nature, 470 (7332), 115-9
    PubMed 21179087
15. Sioud M (2011)
    Promises and challenges in developing RNAi as a research tool and therapy
    Methods Mol Biol, 703, 173-87
    PubMed 21125490
16. Sioud M (2011)
    New insights into mesenchymal stromal cell-mediated T-cell suppression through galectins
    Scand J Immunol, 73 (2), 79-84
    PubMed 21198747
17. Sioud M, Mobergslien A, Boudabous A, Fløisand Y (2011)
    Mesenchymal stem cell-mediated T cell suppression occurs through secreted galectins
    Int J Oncol, 38 (2), 385-90
    PubMed 21165555
18. Soko?owska I, Wälchli S, W?grzyn G, Sandvig K, S?omi?ska-Wojewódzka M (2011)
    A single point mutation in ricin A-chain increases toxin degradation and inhibits EDEM1-dependent ER retrotranslocation
    Biochem J, 436 (2), 371-85
    PubMed 21388347
19. Suso EM, Dueland S, Rasmussen AM, Vetrhus T, Aamdal S, Kvalheim G, Gaudernack G (2011)
    hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes
    Cancer Immunol Immunother, 60 (6), 809-18
    PubMed 21365467
20. Tkacz-Stachowska K, Lund-Andersen C, Velissarou A, Myklebust JH, Stokke T, Syljuåsen RG (2011)
    The amount of DNA damage needed to activate the radiation-induced G2 checkpoint varies between single cells
    Radiother Oncol, 101 (1), 24-7
    PubMed 21722983
21. Torfoss D, Sandstad B, Mollnes TE, Høiby EA, Holte H, Bjerner J, Bjøro T, Gaudernack G, Kvalheim G, Kvaløy S (2011)
    The mild inflammatory response in febrile neutropenic lymphoma patients with low risk of complications is more pronounced in patients receiving tobramycin once daily compared with three times daily
    Scand J Immunol, 74 (6), 632-9
    PubMed 21883353
22. Wedén S, Klemp M, Gladhaug IP, Møller M, Eriksen JA, Gaudernack G, Buanes T (2011)
    Long-term follow-up of patients with resected pancreatic cancer following vaccination against mutant K-ras
    Int J Cancer, 128 (5), 1120-8
    PubMed 20473937
23. Wälchli S, Løset GÅ, Kumari S, Johansen JN, Yang W, Sandlie I, Olweus J (2011)
    A practical approach to T-cell receptor cloning and expression
    PLoS One, 6 (11), e27930
    PubMed 22132171
24. Yri OE, Torfoss D, Hungnes O, Tierens A, Waalen K, Nordøy T, Dudman S, Kilander A, Wader KF, Ostenstad B, Ekanger R, Meyer P, Kolstad A (2011)
    Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment
    Blood, 118 (26), 6769-71
    PubMed 22058114

Publications 2010

1. Abraham D, Zins K, Sioud M, Lucas T, Schäfer R, Stanley ER, Aharinejad S (2010)
   Stromal cell-derived CSF-1 blockade prolongs xenograft survival of CSF-1-negative neuroblastoma
   Int J Cancer, 126 (6), 1339-52
   PubMed 19711348
2. Abrahamsen IW, Stronen E, Wälchli S, Johansen JN, Kjellevoll S, Kumari S, Komada M, Gaudernack G, Tjonnfjord G, Toebes M, Schumacher TN, Lund-Johansen F, Olweus J (2010)
   Targeting B cell leukemia with highly specific allogeneic T cells with a public recognition motif
   Leukemia, 24 (11), 1901-9
   PubMed 20844564
3. Almåsbak H, Lundby M, Rasmussen AM (2010)
   Non-MHC-dependent redirected T cells against tumor cells
   Methods Mol Biol, 629, 453-93
   PubMed 20387166
4. Bakkebø M, Huse K, Hilden VI, Smeland EB, Oksvold MP (2010)
   TGF-?-induced growth inhibition in B-cell lymphoma correlates with Smad1/5 signalling and constitutively active p38 MAPK
   BMC Immunol, 11, 57
   PubMed 21092277
5. Ben-Mahrez K, Sioud M (2010)
   Presence of STRA-STRB linked streptomycin-resistance genes in clinical isolate of Escherichia coil 2418
   Arch Inst Pasteur Tunis, 87 (1-2), 77-81
   PubMed 21598829
6. Bodd M, Ráki M, Tollefsen S, Fallang LE, Bergseng E, Lundin KE, Sollid LM (2010)
   HLA-DQ2-restricted gluten-reactive T cells produce IL-21 but not IL-17 or IL-22
   Mucosal Immunol, 3 (6), 594-601
   PubMed 20571486
7. Bøe S, Saebøe-Larssen S, Hovig E (2010)
   Light-induced gene expression using messenger RNA molecules
   Oligonucleotides, 20 (1), 1-6
   PubMed 20038251
8. Cekaite L, Clancy T, Sioud M (2010)
   Increased miR-21 expression during human monocyte differentiation into DCs
   Front Biosci (Elite Ed), 2, 818-28
   PubMed 20515755
9. Chao MP, Alizadeh AA, Tang C, Myklebust JH, Varghese B, Gill S, Jan M, Cha AC, Chan CK, Tan BT, Park CY, Zhao F, Kohrt HE, Malumbres R, Briones J, Gascoyne RD, Lossos IS, Levy R, Weissman IL, Majeti R (2010)
   Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma
   Cell, 142 (5), 699-713
   PubMed 20813259
10. Davis RE, Ngo VN, Lenz G, Tolar P, Young RM, Romesser PB, Kohlhammer H, Lamy L, Zhao H, Yang Y, Xu W, Shaffer AL, Wright G, Xiao W, Powell J, Jiang JK, Thomas CJ, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Johnson NA, Rimsza LM, Campo E et al. (2010)
    Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
    Nature, 463 (7277), 88-92
    PubMed 20054396
11. Eide MB, Liestøl K, Lingjaerde OC, Hystad ME, Kresse SH, Meza-Zepeda L, Myklebost O, Trøen G, Aamot HV, Holte H, Smeland EB, Delabie J (2010)
    Genomic alterations reveal potential for higher grade transformation in follicular lymphoma and confirm parallel evolution of tumor cell clones
    Blood, 116 (9), 1489-97
    PubMed 20505157
12. Fløisand Y, Sioud M (2010)
    Recent advances in hematopoietic stem cell transplantation and perspectives of RNAi applications
    Methods Mol Biol, 629, 507-23
    PubMed 20387168
13. Fredriksen L, Mathiesen G, Sioud M, Eijsink VG (2010)
    Cell wall anchoring of the 37-kilodalton oncofetal antigen by Lactobacillus plantarum for mucosal cancer vaccine delivery
    Appl Environ Microbiol, 76 (21), 7359-62
    PubMed 20851975
14. Groth M, Wiegand C, Szafranski K, Huse K, Kramer M, Rosenstiel P, Schreiber S, Norgauer J, Platzer M (2010)
    Both copy number and sequence variations affect expression of human DEFB4
    Genes Immun, 11 (6), 458-66
    PubMed 20445567
15. Irish JM, Myklebust JH, Alizadeh AA, Houot R, Sharman JP, Czerwinski DK, Nolan GP, Levy R (2010)
    B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression
    Proc Natl Acad Sci U S A, 107 (29), 12747-54
    PubMed 20543139
16. Iversen PO, Sørensen DR, Sioud M (2010)
    A combined immunostimulatory and immunoinhibitory short interference RNA reduces hypercoagulability in a rat model of acute promyelocytic leukaemia
    Thromb Haemost, 104 (2), 350-4
    PubMed 20539915
17. Kyte JA (2010)
    Third International Conference on Cancer Vaccines/Adjuvants/Delivery for the Next Decade (CVADD 2009)
    Expert Rev Vaccines, 9 (2), 119-23
    PubMed 20109021
18. Kyte JA (2010)
    [We know more than we can understand]
    Tidsskr Nor Laegeforen, 130 (22), 2217
    PubMed 21109831
19. Mobergslien A, Sioud M (2010)
    Optimized protocols for siRNA delivery into monocytes and dendritic cells
    Methods Mol Biol, 629, 71-85
    PubMed 20387143
20. Patzke S, Redick S, Warsame A, Murga-Zamalloa CA, Khanna H, Doxsey S, Stokke T (2010)
    CSPP is a ciliary protein interacting with Nephrocystin 8 and required for cilia formation
    Mol Biol Cell, 21 (15), 2555-67
    PubMed 20519441
21. Rasmussen AM, Borelli G, Hoel HJ, Lislerud K, Gaudernack G, Kvalheim G, Aarvak T (2010)
    Ex vivo expansion protocol for human tumor specific T cells for adoptive T cell therapy
    J Immunol Methods, 355 (1-2), 52-60
    PubMed 20171968
22. Rui L, Emre NC, Kruhlak MJ, Chung HJ, Steidl C, Slack G, Wright GW, Lenz G, Ngo VN, Shaffer AL, Xu W, Zhao H, Yang Y, Lamy L, Davis RE, Xiao W, Powell J, Maloney D, Thomas CJ, Möller P, Rosenwald A, Ott G, Muller-Hermelink HK, Savage K, Connors JM et al. (2010)
    Cooperative epigenetic modulation by cancer amplicon genes
    Cancer Cell, 18 (6), 590-605
    PubMed 21156283
23. Sioud M (2010)
    Advances in RNA sensing by the immune system: separation of siRNA unwanted effects from RNA interference
    Methods Mol Biol, 629, 33-52
    PubMed 20387141
24. Sioud M (2010)
    Development of TLR7/8 small RNA antagonists
    Methods Mol Biol, 629, 387-94
    PubMed 20387163
25. Sioud M (2010)
    RNA therapeutics: function, design, and delivery. Preface
    Methods Mol Biol, 629, v-vii
    PubMed 20394129
26. Sioud M (2010)
    Modulation of dendritic cell maturation and function by siRNA-bearing 5'-triphosphate
    Methods Mol Biol, 629, 395-404
    PubMed 20387164
27. Sioud M (2010)
    Recent advances in small interfering RNA sensing by the immune system
    N Biotechnol, 27 (3), 236-42
    PubMed 20219711
28. Sioud M (2010)
    What are the key targeted delivery technologies of siRNA now?
    Methods Mol Biol, 629, 93-107
    PubMed 20387145
29. Sioud M (2010)
    Overcoming self-tolerance to tumour cells
    Methods Mol Biol, 629, 495-505
    PubMed 20387167
30. Sioud M, Cekaite L (2010)
    Profiling of miRNA expression and prediction of target genes
    Methods Mol Biol, 629, 257-71
    PubMed 20387154
31. Sioud M, Mobergslien A, Boudabous A, Fløisand Y (2010)
    Evidence for the involvement of galectin-3 in mesenchymal stem cell suppression of allogeneic T-cell proliferation
    Scand J Immunol, 71 (4), 267-74
    PubMed 20384870
32. Smeland EB, Vartdal F, Wisløff F (2010)
    [Close cooperation, but not oversteering]
    Tidsskr Nor Laegeforen, 130 (6), 590-1
    PubMed 20348990
33. Smeland EB, Vartdal F, Wisløff F (2010)
    [Leadership and academic competence]
    Tidsskr Nor Laegeforen, 130 (6), 591
    PubMed 20348994
34. Szczepanowicz K, Hoel HJ, Szyk-Warszynska L, Biela?ska E, Bouzga AM, Gaudernack G, Simon C, Warszynski P (2010)
    Formation of biocompatible nanocapsules with emulsion core and pegylated shell by polyelectrolyte multilayer adsorption
    Langmuir, 26 (15), 12592-7
    PubMed 20604580
35. Sørensen DR, Sioud M (2010)
    Systemic delivery of synthetic siRNAs
    Methods Mol Biol, 629, 87-91
    PubMed 20387144
36. Tenstad E, Tourovskaia A, Folch A, Myklebost O, Rian E (2010)
    Extensive adipogenic and osteogenic differentiation of patterned human mesenchymal stem cells in a microfluidic device
    Lab Chip, 10 (11), 1401-1409
    PubMed 20386793
37. Yamazaki T, Wälchli S, Fujita T, Ryser S, Hoshijima M, Schlegel W, Kuroda S, Maturana AD (2010)
    Splice variants of enigma homolog, differentially expressed during heart development, promote or prevent hypertrophy
    Cardiovasc Res, 86 (3), 374-82
    PubMed 20097676

Publications 2009

1. Aharinejad S, Sioud M, Lucas T, Abraham D (2009)
   Targeting stromal-cancer cell interactions with siRNAs
   Methods Mol Biol, 487, 243-66
   PubMed 19301651
2. Cekaite L, Hovig E, Sioud M (2009)
   Monitoring B cell response to immunoselected phage-displayed peptides by microarrays
   Methods Mol Biol, 524, 273-85
   PubMed 19377952
3. Copier J, Dalgleish AG, Britten CM, Finke LH, Gaudernack G, Gnjatic S, Kallen K, Kiessling R, Schuessler-Lenz M, Singh H, Talmadge J, Zwierzina H, Håkansson L (2009)
   Improving the efficacy of cancer immunotherapy
   Eur J Cancer, 45 (8), 1424-31
   PubMed 19167214
4. Flatekval GF, Sioud M (2009)
   Modulation of dendritic cell maturation and function with mono- and bifunctional small interfering RNAs targeting indoleamine 2,3-dioxygenase
   Immunology, 128 (1 Suppl), e837-48
   PubMed 19740345
5. Gao Q, Geng L, Kvalheim G, Gaudernack G, Suo Z (2009)
   Identification of cancer stem-like side population cells in ovarian cancer cell line OVCAR-3
   Ultrastruct Pathol, 33 (4), 175-81
   PubMed 19728235
6. Hauge H, Fjelland KE, Sioud M, Aasheim HC (2009)
   Evidence for the involvement of FAM110C protein in cell spreading and migration
   Cell Signal, 21 (12), 1866-73
   PubMed 19698782
7. Holte H, Kvaløy S, Delabie J, Trøen G, Smeland EB (2009)
   [Molecular diagnosis of malignant lymphomas]
   Tidsskr Nor Laegeforen, 129 (22), 2352-6
   PubMed 19935935
8. Houot R, Goldstein MJ, Kohrt HE, Myklebust JH, Alizadeh AA, Lin JT, Irish JM, Torchia JA, Kolstad A, Chen L, Levy R (2009)
   Therapeutic effect of CD137 immunomodulation in lymphoma and its enhancement by Treg depletion
   Blood, 114 (16), 3431-8
   PubMed 19641184
9. Iversen PO, Semaeva E, Sorensen DR, Wiig H, Sioud M (2009)
   Dendritic Cells Loaded with Tumor Antigens and a Dual Immunostimulatory and Anti-Interleukin 10-Specific Small Interference RNA Prime T Lymphocytes against Leukemic Cells
   Transl Oncol, 2 (4), 242-6
   PubMed 19956385
10. Kyte JA (2009)
    Cancer vaccination with telomerase peptide GV1001
    Expert Opin Investig Drugs, 18 (5), 687-94
    PubMed 19388882
11. Kyte JA (2009)
    [Nobel Prize for mitotic clock]
    Tidsskr Nor Laegeforen, 129 (23), 2470
    PubMed 19997132
12. Kyte JA, Trachsel S, Risberg B, thor Straten P, Lislerud K, Gaudernack G (2009)
    Unconventional cytokine profiles and development of T cell memory in long-term survivors after cancer vaccination
    Cancer Immunol Immunother, 58 (10), 1609-26
    PubMed 19221745
13. Nygren MK, Døsen-Dahl G, Stubberud H, Wälchli S, Munthe E, Rian E (2009)
    beta-catenin is involved in N-cadherin-dependent adhesion, but not in canonical Wnt signaling in E2A-PBX1-positive B acute lymphoblastic leukemia cells
    Exp Hematol, 37 (2), 225-33
    PubMed 19101069
14. O'Riain C, O'Shea DM, Yang Y, Le Dieu R, Gribben JG, Summers K, Yeboah-Afari J, Bhaw-Rosun L, Fleischmann C, Mein CA, Crook T, Smith P, Kelly G, Rosenwald A, Ott G, Campo E, Rimsza LM, Smeland EB, Chan WC, Johnson N, Gascoyne RD, Reimer S, Braziel RM, Wright GW, Staudt LM et al. (2009)
    Array-based DNA methylation profiling in follicular lymphoma
    Leukemia, 23 (10), 1858-66
    PubMed 19587707
15. Rölle A, Olweus J (2009)
    Dendritic cells in cytomegalovirus infection: viral evasion and host countermeasures
    APMIS, 117 (5-6), 413-26
    PubMed 19400865
16. Raa H, Grimmer S, Schwudke D, Bergan J, Wälchli S, Skotland T, Shevchenko A, Sandvig K (2009)
    Glycosphingolipid requirements for endosome-to-Golgi transport of Shiga toxin
    Traffic, 10 (7), 868-82
    PubMed 19453975
17. Sioud M (2009)
    Deciphering the code of innate immunity recognition of siRNAs
    Methods Mol Biol, 487, 41-59
    PubMed 19301641
18. Sioud M (2009)
    Targeted delivery of antisense oligonucleotides and siRNAs into mammalian cells
    Methods Mol Biol, 487, 61-82
    PubMed 19301642
19. Sioud M (2009)
    Does our current understanding of immune tolerance, autoimmunity, and immunosuppressive mechanisms facilitate the design of efficient cancer vaccines?
    Scand J Immunol, 70 (6), 516-25
    PubMed 19906192
20. Sioud M, Boudabous A, Cekaite L (2009)
    Transcriptional responses of Bacillus subtillis and thuringiensis to antibiotics and anti-tumour drugs
    Int J Mol Med, 23 (1), 33-9
    PubMed 19082504
21. Sioud M, Fløisand Y (2009)
    NOD2/CARD15 on bone marrow CD34+ hematopoietic cells mediates induction of cytokines and cell differentiation
    J Leukoc Biol, 85 (6), 939-46
    PubMed 19244164
22. Skånland SS, Wälchli S, Brech A, Sandvig K (2009)
    SNX4 in complex with clathrin and dynein: implications for endosome movement
    PLoS One, 4 (6), e5935
    PubMed 19529763
23. Skånland SS, Wälchli S, Sandvig K (2009)
    ?-arrestins attenuate p38-mediated endosome to Golgi transport
    Cell Microbiol, 11 (5), 796-807
    PubMed 19159388
24. Stronen E, Abrahamsen IW, Gaudernack G, Wälchli S, Munthe E, Buus S, Johansen FE, Lund-Johansen F, Olweus J (2009)
    Dendritic cells engineered to express defined allo-HLA peptide complexes induce antigen-specific cytotoxic T cells efficiently killing tumour cells
    Scand J Immunol, 69 (4), 319-28
    PubMed 19284496
25. Wälchli S, Aasheim HC, Skånland SS, Spilsberg B, Torgersen ML, Rosendal KR, Sandvig K (2009)
    Characterization of clathrin and Syk interaction upon Shiga toxin binding
    Cell Signal, 21 (7), 1161-8
    PubMed 19289168
26. Yri OE, Vig J, Hegstad E, Hovde O, Pignon I, Jynge P (2009)
    Mangafodipir as a cytoprotective adjunct to chemotherapy--a case report
    Acta Oncol, 48 (4), 633-5
    PubMed 19169914

Publications 2008

1. Abraham D, Zins K, Sioud M, Lucas T, Aharinejad S (2008)
   Host CD147 blockade by small interfering RNAs suppresses growth of human colon cancer xenografts
   Front Biosci, 13, 5571-9
   PubMed 18508606
2. Alsøe L, Stacy JE, Fosså A, Funderud S, Brekke OH, Gaudernack G (2008)
   Identification of prostate cancer antigens by automated high-throughput filter immunoscreening
   J Immunol Methods, 330 (1-2), 12-23
   PubMed 18045611
3. Chekenya M, Krakstad C, Svendsen A, Netland IA, Staalesen V, Tysnes BB, Selheim F, Wang J, Sakariassen PØ, Sandal T, Lønning PE, Flatmark T, Enger PØ, Bjerkvig R, Sioud M, Stallcup WB (2008)
   The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling
   Oncogene, 27 (39), 5182-94
   PubMed 18469852
4. Døsen-Dahl G, Munthe E, Nygren MK, Stubberud H, Hystad ME, Rian E (2008)
   Bone marrow stroma cells regulate TIEG1 expression in acute lymphoblastic leukemia cells: role of TGFbeta/BMP-6 and TIEG1 in chemotherapy escape
   Int J Cancer, 123 (12), 2759-66
   PubMed 18798273
5. Furset G, Fløisand Y, Sioud M (2008)
   Impaired expression of indoleamine 2, 3-dioxygenase in monocyte-derived dendritic cells in response to Toll-like receptor-7/8 ligands
   Immunology, 123 (2), 263-71
   PubMed 17725606
6. Holen HL, Shadidi M, Narvhus K, Kjøsnes O, Tierens A, Aasheim HC (2008)
   Signaling through ephrin-A ligand leads to activation of Src-family kinases, Akt phosphorylation, and inhibition of antigen receptor-induced apoptosis
   J Leukoc Biol, 84 (4), 1183-91
   PubMed 18593733
7. Kloster MM, Hafte TT, Moltzau LR, Naderi EH, Dahle MK, Skålhegg BS, Gaudernack G, Levy FO, Naderi S, Blomhoff HK (2008)
   EBV infection renders B cells resistant to growth inhibition via adenylyl cyclase
   Cell Signal, 20 (6), 1169-78
   PubMed 18406106
8. Lenz G, Davis RE, Ngo VN, Lam L, George TC, Wright GW, Dave SS, Zhao H, Xu W, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Fisher RI, Chan WC, Staudt LM (2008)
   Oncogenic CARD11 mutations in human diffuse large B cell lymphoma
   Science, 319 (5870), 1676-9
   PubMed 18323416
9. Lenz G, Wright G, Dave SS, Xiao W, Powell J, Zhao H, Xu W, Tan B, Goldschmidt N, Iqbal J, Vose J, Bast M, Fu K, Weisenburger DD, Greiner TC, Armitage JO, Kyle A, May L, Gascoyne RD, Connors JM, Troen G, Holte H, Kvaloy S, Dierickx D, Verhoef G et al. (2008)
   Stromal gene signatures in large-B-cell lymphomas
   N Engl J Med, 359 (22), 2313-23
   PubMed 19038878
10. Lenz G, Wright GW, Emre NC, Kohlhammer H, Dave SS, Davis RE, Carty S, Lam LT, Shaffer AL, Xiao W, Powell J, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Campo E, Jaffe ES, Delabie J, Smeland EB, Rimsza LM, Fisher RI, Weisenburger DD, Chan WC, Staudt LM (2008)
    Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways
    Proc Natl Acad Sci U S A, 105 (36), 13520-5
    PubMed 18765795
11. Maturana AD, Wälchli S, Iwata M, Ryser S, Van Lint J, Hoshijima M, Schlegel W, Ikeda Y, Tanizawa K, Kuroda S (2008)
    Enigma homolog 1 scaffolds protein kinase D1 to regulate the activity of the cardiac L-type voltage-gated calcium channel
    Cardiovasc Res, 78 (3), 458-65
    PubMed 18296710
12. O'Shea D, O'Riain C, Taylor C, Waters R, Carlotti E, Macdougall F, Gribben J, Rosenwald A, Ott G, Rimsza LM, Smeland EB, Johnson N, Campo E, Greiner TC, Chan WC, Gascoyne RD, Wright G, Staudt LM, Lister TA, Fitzgibbon J (2008)
    The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival
    Blood, 112 (8), 3126-9
    PubMed 18628487
13. Oksvold MP, Dagger SA, Thien CB, Langdon WY (2008)
    The Cbl-b RING finger domain has a limited role in regulating inflammatory cytokine production by IgE-activated mast cells
    Mol Immunol, 45 (4), 925-36
    PubMed 17868870
14. Oksvold MP, Funderud A, Kvissel AK, Skarpen E, Henanger H, Huitfeldt HS, Skålhegg BS, Ørstavik S (2008)
    Epidermal growth factor receptor levels are reduced in mice with targeted disruption of the protein kinase A catalytic subunit
    BMC Cell Biol, 9, 16
    PubMed 18380891
15. Rosseland CM, Wierød L, Flinder LI, Oksvold MP, Skarpen E, Huitfeldt HS (2008)
    Distinct functions of H-Ras and K-Ras in proliferation and survival of primary hepatocytes due to selective activation of ERK and PI3K
    J Cell Physiol, 215 (3), 818-26
    PubMed 18163378
16. Shadidi M, Sørensen D, Dybwad A, Furset G, Sioud M (2008)
    Mucosal vaccination with phage-displayed tumour antigens identified through proteomics-based strategy inhibits the growth and metastasis of 4T1 breast adenocarcinoma
    Int J Oncol, 32 (1), 241-7
    PubMed 18097564
17. Sioud M (2008)
    Does the understanding of immune activation by RNA predict the design of safe siRNAs?
    Front Biosci, 13, 4379-92
    PubMed 18508517
18. Sioud M, Cekaite L (2008)
    Expression profiling of microRNAs in cancer cells: technical considerations
    Methods Mol Biol, 439, 179-90
    PubMed 18370103
19. Skarpen E, Flinder LI, Rosseland CM, Orstavik S, Wierød L, Oksvold MP, Skålhegg BS, Huitfeldt HS (2008)
    MEK1 and MEK2 regulate distinct functions by sorting ERK2 to different intracellular compartments
    FASEB J, 22 (2), 466-76
    PubMed 17928366
20. Sørensen V, Zhen Y, Zakrzewska M, Haugsten EM, Wälchli S, Nilsen T, Olsnes S, Wiedlocha A (2008)
    Phosphorylation of fibroblast growth factor (FGF) receptor 1 at Ser777 by p38 mitogen-activated protein kinase regulates translocation of exogenous FGF1 to the cytosol and nucleus
    Mol Cell Biol, 28 (12), 4129-41
    PubMed 18411303
21. Walchli S, Sioud M (2008)
    Vector-based delivery of siRNAs: in vitro and in vivo challenges
    Front Biosci, 13, 3488-93
    PubMed 18508450
22. Wester T, Jørgensen JJ, Stranden E, Sandbaek G, Tjønnfjord G, Bay D, Kollerøs D, Kroese AJ, Brinchmann JE (2008)
    Treatment with autologous bone marrow mononuclear cells in patients with critical lower limb ischaemia. A pilot study
    Scand J Surg, 97 (1), 56-62
    PubMed 18450207
23. Wierød L, Rosseland CM, Lindeman B, Oksvold MP, Grøsvik H, Skarpen E, Huitfeldt HS (2008)
    Activation of the p53-p21(Cip1) pathway is required for CDK2 activation and S-phase entry in primary rat hepatocytes
    Oncogene, 27 (19), 2763-71
    PubMed 18026139
24. Wälchli S, Skånland SS, Gregers TF, Lauvrak SU, Torgersen ML, Ying M, Kuroda S, Maturana A, Sandvig K (2008)
    The Mitogen-activated protein kinase p38 links Shiga Toxin-dependent signaling and trafficking
    Mol Biol Cell, 19 (1), 95-104
    PubMed 17959827

Publications 2007

1. Aharinejad S, Sioud M, Lucas T, Abraham D (2007)
   Target validation using RNA interference in solid tumors
   Methods Mol Biol, 361, 227-38
   PubMed 17172715
2. Cabezón T, Celis JE, Skibshøj I, Klingelhöfer J, Grigorian M, Gromov P, Rank F, Myklebust JH, Maelandsmo GM, Lukanidin E, Ambartsumian N (2007)
   Expression of S100A4 by a variety of cell types present in the tumor microenvironment of human breast cancer
   Int J Cancer, 121 (7), 1433-44
   PubMed 17565747
3. Cekaite L, Furset G, Hovig E, Sioud M (2007)
   Gene expression analysis in blood cells in response to unmodified and 2'-modified siRNAs reveals TLR-dependent and independent effects
   J Mol Biol, 365 (1), 90-108
   PubMed 17054988
4. Cekaite L, Hovig E, Sioud M (2007)
   Protein arrays: a versatile toolbox for target identification and monitoring of patient immune responses
   Methods Mol Biol, 360, 335-48
   PubMed 17172738
5. Ekstrøm PO, Bjørheim J, Thilly WG (2007)
   Technology to accelerate pangenomic scanning for unknown point mutations in exonic sequences: cycling temperature capillary electrophoresis (CTCE)
   BMC Genet, 8, 54
   PubMed 17697348
6. Ertesvag A, Aasheim HC, Naderi S, Blomhoff HK (2007)
   Vitamin A potentiates CpG-mediated memory B-cell proliferation and differentiation: involvement of early activation of p38MAPK
   Blood, 109 (9), 3865-72
   PubMed 17209053
7. Furset G, Sioud M (2007)
   Design of bifunctional siRNAs: combining immunostimulation and gene-silencing in one single siRNA molecule
   Biochem Biophys Res Commun, 352 (3), 642-9
   PubMed 17150189
8. Hauge H, Patzke S, Aasheim HC (2007)
   Characterization of the FAM110 gene family
   Genomics, 90 (1), 14-27
   PubMed 17499476
9. Hjorthaug HS, Aasheim HC (2007)
   Ephrin-A1 stimulates migration of CD8+CCR7+ T lymphocytes
   Eur J Immunol, 37 (8), 2326-36
   PubMed 17634955
10. Hystad ME, Myklebust JH, Bø TH, Sivertsen EA, Rian E, Forfang L, Munthe E, Rosenwald A, Chiorazzi M, Jonassen I, Staudt LM, Smeland EB (2007)
    Characterization of early stages of human B cell development by gene expression profiling
    J Immunol, 179 (6), 3662-71
    PubMed 17785802
11. Jarnjak-Jankovic S, Hammerstad H, Saebøe-Larssen S, Kvalheim G, Gaudernack G (2007)
    A full scale comparative study of methods for generation of functional Dendritic cells for use as cancer vaccines
    BMC Cancer, 7, 119
    PubMed 17608923
12. Jarnjak-Jankovic S, Saebøe-Larssen S, Kvalheim G, Gaudernack G (2007)
    mRNA transfection of DC in the immature or mature state: comparable in vitro priming of Th and cytotoxic T lymphocytes against DC electroporated with tumor cell line-derived mRNA
    Cytotherapy, 9 (6), 587-92
    PubMed 17882723
13. Kyte JA, Kvalheim G, Lislerud K, thor Straten P, Dueland S, Aamdal S, Gaudernack G (2007)
    T cell responses in melanoma patients after vaccination with tumor-mRNA transfected dendritic cells
    Cancer Immunol Immunother, 56 (5), 659-75
    PubMed 16947019
14. Lehne G, Bjørheim J, Saeter G (2007)
    [Anticancer drug dosing--pharmacogenomic biomarkers or body surface area?]
    Tidsskr Nor Laegeforen, 127 (8), 1040-4
    PubMed 17457389
15. Lenz G, Nagel I, Siebert R, Roschke AV, Sanger W, Wright GW, Dave SS, Tan B, Zhao H, Rosenwald A, Muller-Hermelink HK, Gascoyne RD, Campo E, Jaffe ES, Smeland EB, Fisher RI, Kuehl WM, Chan WC, Staudt LM (2007)
    Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B cell lymphoma
    J Exp Med, 204 (3), 633-43
    PubMed 17353367
16. Nygren MK, Døsen G, Hystad ME, Stubberud H, Funderud S, Rian E (2007)
    Wnt3A activates canonical Wnt signalling in acute lymphoblastic leukaemia (ALL) cells and inhibits the proliferation of B-ALL cell lines
    Br J Haematol, 136 (3), 400-13
    PubMed 17156404
17. Røsok Ø, Sioud M (2007)
    Discovery of differentially expressed genes: technical considerations
    Methods Mol Biol, 360, 115-29
    PubMed 17172727
18. Salaverria I, Zettl A, Beà S, Moreno V, Valls J, Hartmann E, Ott G, Wright G, Lopez-Guillermo A, Chan WC, Weisenburger DD, Gascoyne RD, Grogan TM, Delabie J, Jaffe ES, Montserrat E, Muller-Hermelink HK, Staudt LM, Rosenwald A, Campo E (2007)
    Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature
    J Clin Oncol, 25 (10), 1216-22
    PubMed 17296973
19. Sioud M (2007)
    RNA interference and innate immunity
    Adv Drug Deliv Rev, 59 (2-3), 153-63
    PubMed 17459518
20. Sioud M (2007)
    An overview of the immune system and technical advances in tumor antigen discovery and validation
    Methods Mol Biol, 360, 277-318
    PubMed 17172735
21. Sioud M (2007)
    Main approaches to target discovery and validation
    Methods Mol Biol, 360, 1-12
    PubMed 17172722
22. Sioud M, Fløisand Y (2007)
    TLR agonists induce the differentiation of human bone marrow CD34+ progenitors into CD11c+ CD80/86+ DC capable of inducing a Th1-type response
    Eur J Immunol, 37 (10), 2834-46
    PubMed 17853407
23. Sioud M, Furset G, Cekaite L (2007)
    Suppression of immunostimulatory siRNA-driven innate immune activation by 2'-modified RNAs
    Biochem Biophys Res Commun, 361 (1), 122-6
    PubMed 17658482
24. Sioud M, Leirdal M (2007)
    Druggable signaling proteins
    Methods Mol Biol, 361, 1-24
    PubMed 17172705
25. Sioud M, Melien O (2007)
    Treatment options and individualized medicine
    Methods Mol Biol, 361, 327-40
    PubMed 17172721
26. Sivertsen EA, Huse K, Hystad ME, Kersten C, Smeland EB, Myklebust JH (2007)
    Inhibitory effects and target genes of bone morphogenetic protein 6 in Jurkat TAg cells
    Eur J Immunol, 37 (10), 2937-48
    PubMed 17899540
27. Wiestner A, Tehrani M, Chiorazzi M, Wright G, Gibellini F, Nakayama K, Liu H, Rosenwald A, Muller-Hermelink HK, Ott G, Chan WC, Greiner TC, Weisenburger DD, Vose J, Armitage JO, Gascoyne RD, Connors JM, Campo E, Montserrat E, Bosch F, Smeland EB, Kvaloy S, Holte H, Delabie J, Fisher RI et al. (2007)
    Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival
    Blood, 109 (11), 4599-606
    PubMed 17299095
28. Zins K, Abraham D, Sioud M, Aharinejad S (2007)
    Colon cancer cell-derived tumor necrosis factor-alpha mediates the tumor growth-promoting response in macrophages by up-regulating the colony-stimulating factor-1 pathway
    Cancer Res, 67 (3), 1038-45
    PubMed 17283136
29. Aamot HV, Torlakovic EE, Eide MB, Holte H, Heim S (2007)
    Non-Hodgkin lymphoma with t(14;18): clonal evolution patterns and cytogenetic-pathologic-clinical correlations
    J Cancer Res Clin Oncol, 133 (7), 455-70
    PubMed 17235551

Publications 2006

1. Angell-Petersen E, Spetalen S, Madsen SJ, Sun CH, Peng Q, Carper SW, Sioud M, Hirschberg H (2006)
   Influence of light fluence rate on the effects of photodynamic therapy in an orthotopic rat glioma model
   J Neurosurg, 104 (1), 109-17
   PubMed 16509154
2. Bernhardt SL, Gjertsen MK, Trachsel S, Møller M, Eriksen JA, Meo M, Buanes T, Gaudernack G (2006)
   Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: A dose escalating phase I/II study
   Br J Cancer, 95 (11), 1474-82
   PubMed 17060934
3. Bjørheim J, Frich JC, Gjersvik P, Jacobsen G, Swensen E (2006)
   [Tidsskriftet, peer review and medical publishing]
   Tidsskr Nor Laegeforen, 126 (1), 20-3
   PubMed 16397649
4. Borowiec A, Lechward K, Tkacz-Stachowska K, Sk?adanowski AC (2006)
   Adenosine as a metabolic regulator of tissue function: production of adenosine by cytoplasmic 5'-nucleotidases
   Acta Biochim Pol, 53 (2), 269-78
   PubMed 16770441
5. Brunsvig PF, Aamdal S, Gjertsen MK, Kvalheim G, Markowski-Grimsrud CJ, Sve I, Dyrhaug M, Trachsel S, Møller M, Eriksen JA, Gaudernack G (2006)
   Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer
   Cancer Immunol Immunother, 55 (12), 1553-64
   PubMed 16491401
6. Dave SS, Fu K, Wright GW, Lam LT, Kluin P, Boerma EJ, Greiner TC, Weisenburger DD, Rosenwald A, Ott G, Müller-Hermelink HK, Gascoyne RD, Delabie J, Rimsza LM, Braziel RM, Grogan TM, Campo E, Jaffe ES, Dave BJ, Sanger W, Bast M, Vose JM, Armitage JO, Connors JM, Smeland EB et al. (2006)
   Molecular diagnosis of Burkitt's lymphoma
   N Engl J Med, 354 (23), 2431-42
   PubMed 16760443
7. Døsen G, Tenstad E, Nygren MK, Stubberud H, Funderud S, Rian E (2006)
   Wnt expression and canonical Wnt signaling in human bone marrow B lymphopoiesis
   BMC Immunol, 7, 13
   PubMed 16808837
8. Ekstrøm PO, Bjørheim J (2006)
   Evaluation of sieving matrices used to separate alleles by cycling temperature capillary electrophoresis
   Electrophoresis, 27 (10), 1878-85
   PubMed 16619298
9. Gaudernack G (2006)
   Prospects for vaccine therapy for pancreatic cancer
   Best Pract Res Clin Gastroenterol, 20 (2), 299-314
   PubMed 16549329
10. Huynh T, Wälchli S, Sioud M (2006)
    Transcriptional targeting of small interfering RNAs into cancer cells
    Biochem Biophys Res Commun, 350 (4), 854-9
    PubMed 17034763
11. Ji Z, Yang G, Shahzidi S, Tkacz-Stachowska K, Suo Z, Nesland JM, Peng Q (2006)
    Induction of hypoxia-inducible factor-1alpha overexpression by cobalt chloride enhances cellular resistance to photodynamic therapy
    Cancer Lett, 244 (2), 182-9
    PubMed 16427735
12. Kersten C, Dosen G, Myklebust JH, Sivertsen EA, Hystad ME, Smeland EB, Rian E (2006)
    BMP-6 inhibits human bone marrow B lymphopoiesis--upregulation of Id1 and Id3
    Exp Hematol, 34 (1), 72-81
    PubMed 16413393
13. Kyte JA (2006)
    [Cancer vaccines]
    Tidsskr Nor Laegeforen, 126 (22), 2969-73
    PubMed 17117197
14. Kyte JA, Gaudernack G (2006)
    Immuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells
    Cancer Immunol Immunother, 55 (11), 1432-42
    PubMed 16612595
15. Kyte JA, Mu L, Aamdal S, Kvalheim G, Dueland S, Hauser M, Gullestad HP, Ryder T, Lislerud K, Hammerstad H, Gaudernack G (2006)
    Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA
    Cancer Gene Ther, 13 (10), 905-18
    PubMed 16710345
16. Patzke S, Stokke T, Aasheim HC (2006)
    CSPP and CSPP-L associate with centrosomes and microtubules and differently affect microtubule organization
    J Cell Physiol, 209 (1), 199-210
    PubMed 16826565
17. Ree AH, Stokke T, Bratland A, Patzke S, Nome RV, Folkvord S, Meza-Zepeda LA, Flatmark K, Fodstad O, Andersson Y (2006)
    DNA damage responses in cell cycle G2 phase and mitosis--tracking and targeting
    Anticancer Res, 26 (3A), 1909-16
    PubMed 16827124
18. Saebøe-Larssen S, Fossberg E, Gaudernack G (2006)
    Characterization of novel alternative splicing sites in human telomerase reverse transcriptase (hTERT): analysis of expression and mutual correlation in mRNA isoforms from normal and tumour tissues
    BMC Mol Biol, 7, 26
    PubMed 16939641
19. Sioud M (2006)
    Ribozymes and siRnas: from structure to preclinical applications
    Handb Exp Pharmacol (173), 223-42
    PubMed 16594618
20. Sioud M (2006)
    Single-stranded small interfering RNA are more immunostimulatory than their double-stranded counterparts: a central role for 2'-hydroxyl uridines in immune responses
    Eur J Immunol, 36 (5), 1222-30
    PubMed 16609928
21. Sioud M (2006)
    RNA interference below the immune radar
    Nat Biotechnol, 24 (5), 521-2
    PubMed 16680132
22. Sioud M (2006)
    Innate sensing of self and non-self RNAs by Toll-like receptors
    Trends Mol Med, 12 (4), 167-76
    PubMed 16530484
23. Sioud M (2006)
    RNAi therapy: antibodies guide the way
    Gene Ther, 13 (3), 194-5
    PubMed 17243203
24. Sioud M, Fløisand Y, Forfang L, Lund-Johansen F (2006)
    Signaling through toll-like receptor 7/8 induces the differentiation of human bone marrow CD34+ progenitor cells along the myeloid lineage
    J Mol Biol, 364 (5), 945-54
    PubMed 17049554
25. Sioud M, Furset G (2006)
    Molecular basis for the immunostimulatory potency of small interfering RNAs
    J Biomed Biotechnol, 2006 (4), 23429
    PubMed 17057361
26. Sioud M, Haoudi A (2006)
    RNA interference
    J Biomed Biotechnol, 2006 (4), 89018
    PubMed 17057373
27. Sivertsen EA, Galteland E, Mu D, Holte H, Meza-Zepeda L, Myklebost O, Patzke S, Smeland EB, Stokke T (2006)
    Gain of chromosome 6p is an infrequent cause of increased PIM1 expression in B-cell non-Hodgkin's lymphomas
    Leukemia, 20 (3), 539-42
    PubMed 16437153
28. Sivertsen EA, Hystad ME, Gutzkow KB, Døsen G, Smeland EB, Blomhoff HK, Myklebust JH (2006)
    PI3K/Akt-dependent Epo-induced signalling and target genes in human early erythroid progenitor cells
    Br J Haematol, 135 (1), 117-28
    PubMed 16965383
29. Thomassen GO, Røsok O, Rognes T (2006)
    Computational prediction of microRNAs encoded in viral and other genomes
    J Biomed Biotechnol, 2006 (4), 95270
    PubMed 17057374
30. Winning J, Claus RA, Huse K, Bauer M (2006)
    Molecular biology on the ICU. From understanding to treating sepsis
    Minerva Anestesiol, 72 (5), 255-67
    PubMed 16675935
31. Zheng W, Rosenstiel P, Huse K, Sina C, Valentonyte R, Mah N, Zeitlmann L, Grosse J, Ruf N, Nürnberg P, Costello CM, Onnie C, Mathew C, Platzer M, Schreiber S, Hampe J (2006)
    Evaluation of AGR2 and AGR3 as candidate genes for inflammatory bowel disease
    Genes Immun, 7 (1), 11-8
    PubMed 16222343

Publications 2005

1. Bea S, Zettl A, Wright G, Salaverria I, Jehn P, Moreno V, Burek C, Ott G, Puig X, Yang L, Lopez-Guillermo A, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Gascoyne RD, Connors JM, Grogan TM, Braziel R, Fisher RI, Smeland EB, Kvaloy S, Holte H, Delabie J, Simon R et al. (2005)
   Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction
   Blood, 106 (9), 3183-90
   PubMed 16046532
2. Bjørheim J (2005)
   [Diagnostic mosaic]
   Tidsskr Nor Laegeforen, 125 (21), 2916
   PubMed 16276367
3. Bjørheim J, Ekstrøm PO (2005)
   Review of denaturant capillary electrophoresis in DNA variation analysis
   Electrophoresis, 26 (13), 2520-30
   PubMed 15934053
4. Furre IE, Shahzidi S, Luksiene Z, Møller MT, Borgen E, Morgan J, Tkacz-Stachowska K, Nesland JM, Peng Q (2005)
   Targeting PBR by hexaminolevulinate-mediated photodynamic therapy induces apoptosis through translocation of apoptosis-inducing factor in human leukemia cells
   Cancer Res, 65 (23), 11051-60
   PubMed 16322255
5. Galteland E, Sivertsen EA, Svendsrud DH, Smedshammer L, Kresse SH, Meza-Zepeda LA, Myklebost O, Suo Z, Mu D, Deangelis PM, Stokke T (2005)
   Translocation t(14;18) and gain of chromosome 18/BCL2: effects on BCL2 expression and apoptosis in B-cell non-Hodgkin's lymphomas
   Leukemia, 19 (12), 2313-23
   PubMed 16193090
6. Jarnjak-Jankovic S, Pettersen RD, Saebøe-Larssen S, Wesenberg F, Gaudernack G (2005)
   Evaluation of dendritic cells loaded with apoptotic cancer cells or expressing tumour mRNA as potential cancer vaccines against leukemia
   BMC Cancer, 5, 20
   PubMed 15720715
7. Jarnjak-Jankovic S, Pettersen RD, Saebøe-Larssen S, Wesenberg F, Olafsen MR, Gaudernack G (2005)
   Preclinical evaluation of autologous dendritic cells transfected with mRNA or loaded with apoptotic cells for immunotherapy of high-risk neuroblastoma
   Cancer Gene Ther, 12 (8), 699-707
   PubMed 15846368
8. Kersten C, Sivertsen EA, Hystad ME, Forfang L, Smeland EB, Myklebust JH (2005)
   BMP-6 inhibits growth of mature human B cells; induction of Smad phosphorylation and upregulation of Id1
   BMC Immunol, 6, 9
   PubMed 15877825
9. Kyte JA, Kvalheim G, Aamdal S, Saebøe-Larssen S, Gaudernack G (2005)
   Preclinical full-scale evaluation of dendritic cells transfected with autologous tumor-mRNA for melanoma vaccination
   Cancer Gene Ther, 12 (6), 579-91
   PubMed 15818380
10. Moche M, Hui DS, Huse K, Chan KS, Choy DK, Scholz GH, Gosse H, Winkler J, Schauer J, Sack U, Hoheisel G (2005)
    [Matrix metalloproteinases and their inhibitors in lung cancer with malignant pleural effusion]
    Pneumologie, 59 (8), 523-8
    PubMed 16110415
11. Mu LJ, Kyte JA, Kvalheim G, Aamdal S, Dueland S, Hauser M, Hammerstad H, Waehre H, Raabe N, Gaudernack G (2005)
    Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients
    Br J Cancer, 93 (7), 749-56
    PubMed 16136047
12. Patzke S, Hauge H, Sioud M, Finne EF, Sivertsen EA, Delabie J, Stokke T, Aasheim HC (2005)
    Identification of a novel centrosome/microtubule-associated coiled-coil protein involved in cell-cycle progression and spindle organization
    Oncogene, 24 (7), 1159-73
    PubMed 15580290
13. Røsok O, Sioud M (2005)
    Systematic search for natural antisense transcripts in eukaryotes (review)
    Int J Mol Med, 15 (2), 197-203
    PubMed 15647831
14. Sioud M (2005)
    On the delivery of small interfering RNAs into mammalian cells
    Expert Opin Drug Deliv, 2 (4), 639-51
    PubMed 16296791
15. Sioud M (2005)
    siRNA delivery in vivo
    Methods Mol Biol, 309, 237-49
    PubMed 15990404
16. Sioud M (2005)
    Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization
    J Mol Biol, 348 (5), 1079-90
    PubMed 15854645
17. Sioud M, Iversen PO (2005)
    Ribozymes, DNAzymes and small interfering RNAs as therapeutics
    Curr Drug Targets, 6 (6), 647-53
    PubMed 16178798
18. Sioud M, Røsok Ø (2005)
    High-throughput analysis of microRNA gene expression using sensitive probes
    Methods Mol Biol, 309, 311-20
    PubMed 15990410
19. Sioud M, Wälchli S (2005)
    Strategies for the design of random siRNA libraries and the selection of anti-GFP siRNAs
    Methods Mol Biol, 309, 83-91
    PubMed 15990399
20. Tkacz-Stachowska K, Lechward K, Skladanowski AC (2005)
    Isolation and characterization of pigeon breast muscle cytosolic 5'-nucleotidase-I (cN-I)
    Acta Biochim Pol, 52 (4), 789-96
    PubMed 15940349
21. Torlakovic E, Malecka A, Myklebust JH, Tierens A, Aasheim HC, Nesland JM, Smeland E, Kvaløy S, Delabie J (2005)
    PU.1 protein expression has a positive linear association with protein expression of germinal centre B cell genes including BCL-6, CD10, CD20 and CD22: identification of PU.1 putative binding sites in the BCL-6 promotor
    J Pathol, 206 (3), 312-9
    PubMed 15892171
22. Torlakovic E, Tenstad E, Funderud S, Rian E (2005)
    CD10+ stromal cells form B-lymphocyte maturation niches in the human bone marrow
    J Pathol, 205 (3), 311-7
    PubMed 15682430
23. Aasheim HC, Delabie J, Finne EF (2005)
    Ephrin-A1 binding to CD4+ T lymphocytes stimulates migration and induces tyrosine phosphorylation of PYK2
    Blood, 105 (7), 2869-76
    PubMed 15585656
24. Aasheim HC, Patzke S, Hjorthaug HS, Finne EF (2005)
    Characterization of a novel Eph receptor tyrosine kinase, EphA10, expressed in testis
    Biochim Biophys Acta, 1723 (1-3), 1-7
    PubMed 15777695

Publications 2004

1. Aharinejad S, Paulus P, Sioud M, Hofmann M, Zins K, Schäfer R, Stanley ER, Abraham D (2004)
   Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice
   Cancer Res, 64 (15), 5378-84
   PubMed 15289345
2. Breivik J, Gaudernack G (2004)
   Resolving the evolutionary paradox of genetic instability: a cost-benefit analysis of DNA repair in changing environments
   FEBS Lett, 563 (1-3), 7-12
   PubMed 15063714
3. Cekaite L, Haug O, Myklebost O, Aldrin M, Østenstad B, Holden M, Frigessi A, Hovig E, Sioud M (2004)
   Analysis of the humoral immune response to immunoselected phage-displayed peptides by a microarray-based method
   Proteomics, 4 (9), 2572-82
   PubMed 15352232
4. Dai KZ, Johansen FE, Kolltveit KM, Aasheim HC, Dembic Z, Vartdal F, Spurkland A (2004)
   Transcriptional activation of the SH2D2A gene is dependent on a cyclic adenosine 5'-monophosphate-responsive element in the proximal SH2D2A promoter
   J Immunol, 172 (10), 6144-51
   PubMed 15128801
5. Dave SS, Wright G, Tan B, Rosenwald A, Gascoyne RD, Chan WC, Fisher RI, Braziel RM, Rimsza LM, Grogan TM, Miller TP, LeBlanc M, Greiner TC, Weisenburger DD, Lynch JC, Vose J, Armitage JO, Smeland EB, Kvaloy S, Holte H, Delabie J, Connors JM, Lansdorp PM, Ouyang Q, Lister TA et al. (2004)
   Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells
   N Engl J Med, 351 (21), 2159-69
   PubMed 15548776
6. Elahi EN, Wright Z, Hinselwood D, Hotchkiss SA, Basketter DA, Pease CK (2004)
   Protein binding and metabolism influence the relative skin sensitization potential of cinnamic compounds
   Chem Res Toxicol, 17 (3), 301-10
   PubMed 15025500
7. Finne EF, Munthe E, Aasheim HC (2004)
   A new ephrin-A1 isoform (ephrin-A1b) with altered receptor binding properties abrogates the cleavage of ephrin-A1a
   Biochem J, 379 (Pt 1), 39-46
   PubMed 14692877
8. Fosså A, Alsøe L, Crameri R, Funderud S, Gaudernack G, Smeland EB (2004)
   Serological cloning of cancer/testis antigens expressed in prostate cancer using cDNA phage surface display
   Cancer Immunol Immunother, 53 (5), 431-8
   PubMed 14747957
9. Fosså A, Berner A, Fosså SD, Hernes E, Gaudernack G, Smeland EB (2004)
   NY-ESO-1 protein expression and humoral immune responses in prostate cancer
   Prostate, 59 (4), 440-7
   PubMed 15065093
10. Hauge H, Patzke S, Delabie J, Aasheim HC (2004)
    Characterization of a novel immunoglobulin-like domain containing receptor
    Biochem Biophys Res Commun, 323 (3), 970-8
    PubMed 15381095
11. Hirschberg H, Madsen S, Angell-Petersen E, Peng Q, Sioud M, Sun CH, Sorensen DR (2004)
    Repetitive 5-aminolevulinic acid mediated photodynamic therapy of rat glioma
    P SOC PHOTO-OPT INS, 5312, 405-414
12. Holm AM, Sivertsen EA, Tunheim SH, Haug T, Bjerkeli V, Yndestad A, Aukrust P, Frøland SS (2004)
    Gene expression analysis of peripheral T cells in a subgroup of common variable immunodeficiency shows predominance of CCR7(-) effector-memory T cells
    Clin Exp Immunol, 138 (2), 278-89
    PubMed 15498038
13. Iversen PO, Sioud M (2004)
    Inhibition of gene expression by nucleic acid enzymes in rodent models of human disease
    Methods Mol Biol, 252, 451-6
    PubMed 15017070
14. Kersten C, Delabie J, Gaudernack G, Smeland EB, Fosså A (2004)
    Analysis of the autoantibody repertoire in Burkitt's lymphoma patients: frequent response against the transcription factor ATF-2
    Cancer Immunol Immunother, 53 (12), 1119-26
    PubMed 15185015
15. Kristensen AT, Bjørheim J, Wiig J, Giercksky KE, Ekstrøm PO (2004)
    DNA variants in the ATM gene are not associated with sporadic rectal cancer in a Norwegian population-based study
    Int J Colorectal Dis, 19 (1), 49-54
    PubMed 12827413
16. Lazarova P, Lijun M, Hammerstad H, Nesland J, Gaudernack G, Kvalheim G (2004)
    Experimental attempt to introduce a vaccine therapy by using DC-developed from CD34+cells
    NATO SCI SER I LIFE, 361, 134
17. Leirdal M, Shadidy M, Røsok Ø, Sioud M (2004)
    Identification of genes differentially expressed in breast cancer cell line SKBR3: potential identification of new prognostic biomarkers
    Int J Mol Med, 14 (2), 217-22
    PubMed 15254768
18. Leirdal M, Sioud M (2004)
    Gene-array analysis of glioma cells after treatment with an anti-PKCalpha siRNA: a general protocol
    Methods Mol Biol, 252, 493-500
    PubMed 15017074
19. Lyngstadaas A, Husebekk A, Funderud S, Brinch L (2004)
    [Clinical use of haematopoietic stem cells from cord blood]
    Tidsskr Nor Laegeforen, 124 (22), 2928-31
    PubMed 15550970
20. Mu LJ, Lazarova P, Gaudernack G, Saeboe-Larssen S, Kvalheim G (2004)
    Development of a clinical grade procedure for generation of mRNA transfected dendritic cells from purified frozen CD34(+) blood progenitor cells
    Int J Immunopathol Pharmacol, 17 (3), 255-63
    PubMed 15461859
21. Munthe E, Finne EF, Aasheim HC (2004)
    Expression and functional effects of Eph receptor tyrosine kinase A family members on Langerhans like dendritic cells
    BMC Immunol, 5, 9
    PubMed 15176971
22. Reppe S, Olstad OK, Rian E, Gautvik VT, Gautvik KM, Jemtland R (2004)
    Butyrate response factor 1 is regulated by parathyroid hormone and bone morphogenetic protein-2 in osteoblastic cells
    Biochem Biophys Res Commun, 324 (1), 218-23
    PubMed 15465005
23. Røsok O, Sioud M (2004)
    An experimental approach for systematic identification of antisense transcripts
    Discov Med, 4 (20), 58-60
    PubMed 20705023
24. Røsok Ø, Sioud M (2004)
    Systematic identification of sense-antisense transcripts in mammalian cells
    Nat Biotechnol, 22 (1), 104-8
    PubMed 14704709
25. Shadidi M, Sioud M (2004)
    Selection of peptides for specific delivery of oligonucleotides into cancer cells
    Methods Mol Biol, 252, 569-80
    PubMed 15017081
26. Sinnreich O, Kratzsch J, Reichenbach A, Gläser C, Huse K, Birkenmeier G (2004)
    Plasma levels of transforming growth factor-1beta and alpha2-macroglobulin before and after radical prostatectomy: association to clinicopathological parameters
    Prostate, 61 (3), 201-8
    PubMed 15368477
27. Sioud M (2004)
    Therapeutic potential of small interfering RNAs
    Drug Future, 29 (7), 741-750
28. Sioud M (2004)
    Therapeutic siRNAs
    Trends Pharmacol Sci, 25 (1), 22-8
    PubMed 14723975
29. Sioud M (2004)
    Ribozyme- and siRNA-mediated mRNA degradation: a general introduction
    Methods Mol Biol, 252, 1-8
    PubMed 15017038
30. Sioud M, Leirdal M (2004)
    Potential design rules and enzymatic synthesis of siRNAs
    Methods Mol Biol, 252, 457-69
    PubMed 15017071
31. Sioud M, Røsok O (2004)
    Profiling microRNA expression using sensitive cDNA probes and filter arrays
    Biotechniques, 37 (4), 574-6, 578-80
    PubMed 15517969
32. Sioud M, Sørensen DR (2004)
    Systemic delivery of synthetic siRNAs
    Methods Mol Biol, 252, 515-22
    PubMed 15017077
33. Sivertsen EA, Torfoss D (2004)
    [Cryptococcal meningitis]
    Tidsskr Nor Laegeforen, 124 (1), 28-30
    PubMed 14716388

Publications 2003

1. Birkenmeier G, Müller R, Huse K, Forberg J, Gläser C, Hedrich H, Nicklisch S, Reichenbach A (2003)
   Human alpha2-macroglobulin: genotype-phenotype relation
   Exp Neurol, 184 (1), 153-61
   PubMed 14637088
2. Bjorheim J, Minarik M, Gaudernack G, Ekstrom PO (2003)
   Evaluation of denaturing conditions in analysis of DNA variants applied to multi-capillary electrophoresis instruments
   J. Sep. Sci., 26 (12-13), 1163-1168
3. Bjørheim J, Abrahamsen TW, Kristensen AT, Gaudernack G, Ekstrøm PO (2003)
   Approach to analysis of single nucleotide polymorphisms by automated constant denaturant capillary electrophoresis
   Mutat Res, 526 (1-2), 75-83
   PubMed 12714185
4. Bjørheim J, Gaudernack G, Giercksky KE, Ekstrøm PO (2003)
   Direct identification of all oncogenic mutants in KRAS exon 1 by cycling temperature capillary electrophoresis
   Electrophoresis, 24 (1-2), 63-9
   PubMed 12652573
5. Bønsdorff T, Eggen A, Gautier M, Asheim HC, Rønningen K, Lingaas F, Olsaker I (2003)
   Identification and physical mapping of genes expressed in the corpus luteum in cattle
   Anim Genet, 34 (5), 325-33
   PubMed 14510667
6. Dybwad A, Lambin P, Sioud M, Zouali M (2003)
   Probing the specificity of human myeloma proteins with a random peptide phage library
   Scand J Immunol, 57 (6), 583-90
   PubMed 12791097
7. Gjertsen MK, Saeterdal I, Saebøe-Larssen S, Gaudernack G (2003)
   HLA-A3 restricted mutant ras specific cytotoxic T-lymphocytes induced by vaccination with T-helper epitopes
   J Mol Med (Berl), 81 (1), 43-50
   PubMed 12545248
8. Minarik M, Minarikova L, Bjørheim J, Ekstrøm PO (2003)
   Cycling gradient capillary electrophoresis: a low-cost tool for high-throughput analysis of genetic variations
   Electrophoresis, 24 (11), 1716-22
   PubMed 12783447
9. Mu LJ, Gaudernack G, Saebøe-Larssen S, Hammerstad H, Tierens A, Kvalheim G (2003)
   A protocol for generation of clinical grade mRNA-transfected monocyte-derived dendritic cells for cancer vaccines
   Scand J Immunol, 58 (5), 578-86
   PubMed 14629630
10. Olstad OK, Gautvik VT, Reppe S, Rian E, Jemtland R, Ohlsson C, Bruland OS, Gautvik KM (2003)
    Molecular heterogeneity in human osteosarcoma demonstrated by enriched mRNAs isolated by directional tag PCR subtraction cloning
    Anticancer Res, 23 (3B), 2201-16
    PubMed 12894494
11. Paus E, Almåsbak H, Børmer OP, Warren DJ (2003)
    A single-chain-Fv-based immunofluorometric assay specific for the CEA variant NCA-2
    J Immunol Methods, 283 (1-2), 125-39
    PubMed 14659905
12. Rosenwald A, Wright G, Leroy K, Yu X, Gaulard P, Gascoyne RD, Chan WC, Zhao T, Haioun C, Greiner TC, Weisenburger DD, Lynch JC, Vose J, Armitage JO, Smeland EB, Kvaloy S, Holte H, Delabie J, Campo E, Montserrat E, Lopez-Guillermo A, Ott G, Muller-Hermelink HK, Connors JM, Braziel R et al. (2003)
    Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma
    J Exp Med, 198 (6), 851-62
    PubMed 12975453
13. Rosenwald A, Wright G, Wiestner A, Chan WC, Connors JM, Campo E, Gascoyne RD, Grogan TM, Muller-Hermelink HK, Smeland EB, Chiorazzi M, Giltnane JM, Hurt EM, Zhao H, Averett L, Henrickson S, Yang L, Powell J, Wilson WH, Jaffe ES, Simon R, Klausner RD, Montserrat E, Bosch F, Greiner TC et al. (2003)
    The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma
    Cancer Cell, 3 (2), 185-97
    PubMed 12620412
14. Shadidi M, Sioud M (2003)
    Identification of novel carrier peptides for the specific delivery of therapeutics into cancer cells
    FASEB J, 17 (2), 256-8
    PubMed 12490548
15. Shadidi M, Sioud M (2003)
    Selective targeting of cancer cells using synthetic peptides
    Drug Resist Updat, 6 (6), 363-71
    PubMed 14744500
16. Sioud M, Sørensen D (2003)
    Generation of an effective anti-tumor immunity after immunization with xenogeneic antigens
    Eur J Immunol, 33 (1), 38-45
    PubMed 12594830
17. Sioud M, Sørensen DR (2003)
    Cationic liposome-mediated delivery of siRNAs in adult mice
    Biochem Biophys Res Commun, 312 (4), 1220-5
    PubMed 14652004
18. Stacy JE, Kausmally L, Simonsen B, Nordgard SH, Alsøe L, Michaelsen TE, Brekke OH (2003)
    Direct isolation of recombinant human antibodies against group B Neisseria meningitidis from scFv expression libraries
    J Immunol Methods, 283 (1-2), 247-59
    PubMed 14659916
19. Sørensen DR, Leirdal M, Sioud M (2003)
    Gene silencing by systemic delivery of synthetic siRNAs in adult mice
    J Mol Biol, 327 (4), 761-6
    PubMed 12654261
20. Taraldsrud E, Kvalheim G, Jørstad S, Stavem K, Aandahl GS (2003)
    A survey of therapeutic hemapheresis in Norway year 2000
    Transfus Apher Sci, 28 (2), 135-41
    PubMed 12679117
21. Wabakken T, Rian E, Kveine M, Aasheim HC (2003)
    The human solute carrier SLC41A1 belongs to a novel eukaryotic subfamily with homology to prokaryotic MgtE Mg2+ transporters
    Biochem Biophys Res Commun, 306 (3), 718-24
    PubMed 12810078

Publications 2002

1. Bjorheim J, Gaudernack G, Ekstrom PO (2002)
   Melting gel techniques in single nucleotide polymorphism and mutation detection: From theory to automation
   J. Sep. Sci., 25 (10-11), 637-647
2. Bjørheim J, Minarik M, Gaudernack G, Ekstrøm PO (2002)
   Mutation detection in KRAS Exon 1 by constant denaturant capillary electrophoresis in 96 parallel capillaries
   Anal Biochem, 304 (2), 200-5
   PubMed 12009696
3. Ekstrøm PO, Bjørheim J (2002)
   Reducing the cost of consumables used for ABI 310 genetic analyzer
   Anal Biochem, 306 (1), 148-9
   PubMed 12069426
4. Ekstrøm PO, Bjørheim J, Gaudernack G, Giercksky KE (2002)
   Population screening of single-nucleotide polymorphisms exemplified by analysis of 8000 alleles
   J Biomol Screen, 7 (6), 501-6
   PubMed 14599347
5. Fosså A, Lilleby W, Fosså SD, Gaudernack G, Torlakovic G, Berner A (2002)
   Independent prognostic significance of HER-2 oncoprotein expression in pN0 prostate cancer undergoing curative radiotherapy
   Int J Cancer, 99 (1), 100-5
   PubMed 11948499
6. Iversen PO, Emanuel PD, Sioud M (2002)
   Targeting Raf-1 gene expression by a DNA enzyme inhibits juvenile myelomonocytic leukemia cell growth
   Blood, 99 (11), 4147-53
   PubMed 12010819
7. Kristensen AT, Bjørheim J, Ekstrøm PO (2002)
   Detection of mutations in exon 8 of TP53 by temperature gradient 96-capillary array electrophoresis
   Biotechniques, 33 (3), 650-3
   PubMed 12238774
8. Kveine M, Tenstad E, Døsen G, Funderud S, Rian E (2002)
   Characterization of the novel human transmembrane protein 9 (TMEM9) that localizes to lysosomes and late endosomes
   Biochem Biophys Res Commun, 297 (4), 912-7
   PubMed 12359240
9. Leirdal M, Sioud M (2002)
   [Tyrosine kinase receptor-ras-ERK signal transduction pathway as therapeutic tarfet in cancer]
   Tidsskr Nor Laegeforen, 122 (2), 178-82
   PubMed 11873574
10. Leirdal M, Sioud M (2002)
    Gene silencing in mammalian cells by preformed small RNA duplexes
    Biochem Biophys Res Commun, 295 (3), 744-8
    PubMed 12099702
11. Lundqvist A, Noffz G, Pavlenko M, Saebøe-Larssen S, Fong T, Maitland N, Pisa P (2002)
    Nonviral and viral gene transfer into different subsets of human dendritic cells yield comparable efficiency of transfection
    J Immunother, 25 (6), 445-54
    PubMed 12439342
12. Machon O, van den Bout CJ, Backman M, Røsok Ø, Caubit X, Fromm SH, Geronimo B, Krauss S (2002)
    Forebrain-specific promoter/enhancer D6 derived from the mouse Dach1 gene controls expression in neural stem cells
    Neuroscience, 112 (4), 951-66
    PubMed 12088753
13. Munthe E, Aasheim HC (2002)
    Characterization of the human ephrin-A4 promoter
    Biochem J, 366 (Pt 2), 447-58
    PubMed 12030849
14. Myklebust JH, Blomhoff HK, Rusten LS, Stokke T, Smeland EB (2002)
    Activation of phosphatidylinositol 3-kinase is important for erythropoietin-induced erythropoiesis from CD34(+) hematopoietic progenitor cells
    Exp Hematol, 30 (9), 990-1000
    PubMed 12225790
15. Patzke S, Lindeskog M, Munthe E, Aasheim HC (2002)
    Characterization of a novel human endogenous retrovirus, HERV-H/F, expressed in human leukemia cell lines
    Virology, 303 (1), 164-73
    PubMed 12482668
16. Paulsen JE, Bjørheim J, Røe J, Eide TJ, Alexander J, Gaudernack G (2002)
    Effect of vaccination with mutant KRAS peptides on rat colon carcinogenesis induced by azoxymethane
    Anticancer Res, 22 (1A), 171-5
    PubMed 12017282
17. Ree AH, Bratland A, Kroes RA, Aasheim HC, Flørenes VA, Moskal JR, Fodstad O, Bruland OS, Maelandsmo GM (2002)
    Clinical and cell line specific expression profiles of a human gene identified in experimental central nervous system metastases
    Anticancer Res, 22 (4), 1949-57
    PubMed 12174869
18. Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland EB, Giltnane JM, Hurt EM, Zhao H, Averett L, Yang L, Wilson WH, Jaffe ES, Simon R, Klausner RD, Powell J, Duffey PL, Longo DL, Greiner TC, Weisenburger DD, Sanger WG, Dave BJ et al. (2002)
    The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
    N Engl J Med, 346 (25), 1937-47
    PubMed 12075054
19. Saebøe-Larssen S, Fossberg E, Gaudernack G (2002)
    mRNA-based electrotransfection of human dendritic cells and induction of cytotoxic T lymphocyte responses against the telomerase catalytic subunit (hTERT)
    J Immunol Methods, 259 (1-2), 191-203
    PubMed 11730854
20. Sioud M (2002)
    How does autoimmunity cause tumor regression? A potential mechanism involving cross-reaction through epitope mimicry
    Mol Med, 8 (3), 115-9
    PubMed 12142543
21. Sorensen DR, Leirdal M, Iversen PO, Sioud M (2002)
    Combination of endostatin and a protein kinase Calpha DNA enzyme improves the survival of rats with malignant glioma
    Neoplasia, 4 (6), 474-9
    PubMed 12407440
22. van den Bout CJ, Machon O, Røsok Ø, Backman M, Krauss S (2002)
    The mouse enhancer element D6 directs Cre recombinase activity in the neocortex and the hippocampus
    Mech Dev, 110 (1-2), 179-82
    PubMed 11744379
23. Wabakken T, Hauge H, Finne EF, Wiedlocha A, Aasheim H (2002)
    Expression of human protein tyrosine phosphatase epsilon in leucocytes: a potential ERK pathway-regulating phosphatase
    Scand J Immunol, 56 (2), 195-203
    PubMed 12121439
24. Wabakken T, Hauge H, Funderud S, Aasheim HC (2002)
    Characterization, expression and functional aspects of a novel protein tyrosine phosphatase epsilon isoform
    Scand J Immunol, 56 (3), 276-85
    PubMed 12193229
25. Wang J, Delabie J, Aasheim H, Smeland E, Myklebost O (2002)
    Clustering of the SOM easily reveals distinct gene expression patterns: results of a reanalysis of lymphoma study
    BMC Bioinformatics, 3, 36
    PubMed 12445336